https://www.selleckchem.com/pr....oducts/telotristat-e
r BRCAm, the economic impact of these treatments will be important to consider relative to their survival benefits. The purpose of this study was to assess pediatric hematology clinic staff's perspectives regarding barriers and facilitators in addressing unmet basic needs for children with sickle cell disease (SCD). Six focus groups were held at four urban pediatric hematology clinics in the Northeastern region of the United States from November to December 2019. Discussion questions were developed to alig